Literature DB >> 7384094

Requirements for an idealized animal model of prostatic cancer.

D S Coffey, J T Isaacs.   

Abstract

Numerous contributions to our understanding of the human prostate have been obtained from previous animal studies. The use of newly available animal models of prostatic adenocarcinoma described in this paper should provide the means for further developing new concepts that can be tested in the human disease. In so doing, each animal model must first be characterized and demonstrated as being an appropriate model for a particular form of the human tumor. In this regard this review has discussed several important considerations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7384094

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  5 in total

1.  Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate.

Authors:  W L McKeehan; P S Adams; D Fast
Journal:  In Vitro Cell Dev Biol       Date:  1987-02

Review 2.  Rodent models for targeted oncogenesis of the prostate gland.

Authors:  R Buttyan; K Slawin
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

3.  Maturation of the developing human fetal prostate in a rodent xenograft model.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell; Ali Amin; Daniel J Spade; Susan M Huse; Stefan Kostadinov; Susan J Hall; Kim Boekelheide
Journal:  Prostate       Date:  2013-08-30       Impact factor: 4.104

4.  Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell-Clark; Ali Amin; Susan M Huse; Kim Boekelheide
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Establishment and Evaluation of a Rat Model of Sidestream Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

Authors:  Genfa Wang; Nabijan Mohammadtursun; Jing Sun; Yubao Lv; Hualiang Jin; Jinpei Lin; Lingwen Kong; Zhengxiao Zhao; Hongying Zhang; Jingcheng Dong
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.